Research Article
Taxpas: Epidemiological and Survival Data in Breast Cancer Patients Treated with a Docetaxel-Based Chemotherapy Regimen in South Africa
Table 4
Statistical analyses based on survival curves: TNBC versus N-TNBC.
| | ≤50 years | >50 years | Logrank value | Hazard ratio (95% confidence interval) | Logrank value | Hazard ratio |
| Stage I | | 0.352 (0.022–5.631) | | Not calculable | Stage II | = Not calculable | Not calculable | | 0.512 (0.053–4.926) | Stage III | | 0.133 (0.019–0.943)* | | 0.138 (0.031–0.619)* | Stage IV | | 0.444 (0.231–0.853)* | | 0.718 (0.417–1.235) |
|
|